ClinicalTrials.gov record
Recruiting Phase 4 Interventional

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

ClinicalTrials.gov ID: NCT04373564

Public ClinicalTrials.gov record NCT04373564. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 27, 2026, 7:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prospective Evaluation of Potential Effects of Repeated Gadolinium-based Contrast Agent (GBCA) Administrations of the Same GBCA on Motor and Cognitive Functions in Neurologically Normal Adults in Comparison to a Non-GBCA Exposed Control Group

Study identification

NCT ID
NCT04373564
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 4
Lead sponsor
Guerbet
Industry
Enrollment
2,076 participants

Conditions and interventions

Interventions

  • Cognitive Tests Procedure
  • Gadobenate dimeglumine Drug
  • Gadobutrol Drug
  • Gadodiamide Drug
  • Gadolinium Measurements Procedure
  • Gadoterate meglumine Drug
  • Gadoteridol Drug
  • Gadoxetate disodium Drug
  • Motor Tests Procedure
  • Unenhanced-MRI of the brain Procedure

Procedure · Drug

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 23, 2021
Primary completion
Dec 30, 2028
Completion
Dec 30, 2028
Last update posted
Jan 21, 2026

2021 – 2028

United States locations

U.S. sites
16
U.S. states
9
U.S. cities
14
Facility City State ZIP Site status
Scottsdale Medical Imaging, LLC Scottsdale Arizona 85260 Recruiting
Yale University School of Medicine New Haven Connecticut 06520 Withdrawn
University of Chicago Medical Center Chicago Illinois 60637 Recruiting
Methodist Medical Center of Illinois Peoria Illinois 61637 Recruiting
Massachussets General Hospital Boston Massachusetts 02114 Recruiting
Boston University Medical Center Boston Massachusetts 02118 Terminated
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 Withdrawn
ActivMed Practices & Research, Inc. Methuen Massachusetts 01844 Withdrawn
University of Massachusetts Memorial Medical Center Worcester Massachusetts 01655 Terminated
Department of Radiology St Louis Missouri 63110 Withdrawn
UNC School of Medicine Chapel Hill North Carolina 27599 Withdrawn
Penn State Hershey Medical Center Hershey Pennsylvania 17033 Recruiting
Albert Einstein Healthcare Network Philadelphia Pennsylvania 19141 Recruiting
UT Southwestern Medical Center Dallas Texas 75390 Recruiting
MD Anderson Cancer Center Houston Texas 77030 Withdrawn
University of Wisconsin Madison Wisconsin 53792 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04373564, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 21, 2026 · Synced Apr 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04373564 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →